Cargando…

IL‐23R Deficiency Does Not Impact Atherosclerotic Plaque Development in Mice

BACKGROUND: Interleukin‐23 (IL‐23) has been implicated in inflammatory and autoimmune diseases by skewing CD4(+) T helper cells towards a pathogenic Th17 phenotype. In this study we investigated the presence of IL‐23 receptor (IL‐23R)‐expressing cells in the atherosclerotic aorta and evaluated the e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Engelbertsen, Daniel, Depuydt, Marie A. C., Verwilligen, Robin A. F., Rattik, Sara, Levinsohn, Erik, Edsfeldt, Andreas, Kuperwaser, Felicia, Jarolim, Petr, Lichtman, Andrew H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015431/ https://www.ncbi.nlm.nih.gov/pubmed/29618473 http://dx.doi.org/10.1161/JAHA.117.008257

Ejemplares similares

Increased lymphocyte activation and atherosclerosis in CD47-deficient mice
por: Engelbertsen, Daniel, et al.
Publicado: (2019)

LAG3 Regulates T Cell Activation and Plaque Infiltration in Atherosclerotic Mice
por: Mulholland, Megan, et al.
Publicado: (2022)

Transforming growth factor-β2 is associated with atherosclerotic plaque stability and lower risk for cardiovascular events
por: Edsfeldt, Andreas, et al.
Publicado: (2023)

Human Atherosclerotic Plaque Progression Is Dependent on Apoptosis According to Bomb-Pulse (14)C Dating
por: Edsfeldt, Andreas, et al.
Publicado: (2021)

Altered metabolism distinguishes high-risk from stable carotid atherosclerotic plaques
por: Tomas, Lukas, et al.
Publicado: (2018)

Visfatin Destabilizes Atherosclerotic Plaques in Apolipoprotein E–Deficient Mice
por: Li, Bo, et al.
Publicado: (2016)

Macrophage ATP citrate lyase deficiency stabilizes atherosclerotic plaques
por: Baardman, Jeroen, et al.
Publicado: (2020)

Angiogenesis in the atherosclerotic plaque
por: Camaré, Caroline, et al.
Publicado: (2017)

Treatment with a GnRH receptor agonist, but not the GnRH receptor antagonist degarelix, induces atherosclerotic plaque instability in ApoE(−/−) mice
por: Knutsson, Anki, et al.
Publicado: (2016)

Microanatomy of the Human Atherosclerotic Plaque by Single-Cell Transcriptomics
por: Depuydt, Marie A.C., et al.
Publicado: (2020)

Regulated cell death joins in atherosclerotic plaque silent progression
por: Uyy, Elena, et al.
Publicado: (2022)

Deficiency of Adipocyte IKKβ Affects Atherosclerotic Plaque Vulnerability in Obese LDLR Deficient Mice
por: Lu, Weiwei, et al.
Publicado: (2019)

Imaging the carotid atherosclerotic plaque
por: Neumann, Sandra, et al.
Publicado: (2019)

Dystrophin deficiency reduces atherosclerotic plaque development in ApoE-null mice
por: Shami, Annelie, et al.
Publicado: (2015)

Atherosclerotic Plaque Biomarkers: Beyond the Horizon of the Vulnerable Plaque
por: W. van Lammeren, Guus, et al.
Publicado: (2011)

In-vivo T2 mapping of atherosclerotic plaques in carotid arteries
por: Biasiolli, Luca, et al.
Publicado: (2012)

Whole body and hematopoietic ADAM8 deficiency does not influence advanced atherosclerotic lesion development, despite its association with human plaque progression
por: Theodorou, Kosta, et al.
Publicado: (2017)

The role of the chemokines MCP-1, GRO-α, IL-8 and their receptors in the adhesion of monocytic cells to human atherosclerotic plaques
por: Papadopoulou, Charikleia, et al.
Publicado: (2008)

The role of near-infrared spectroscopy in the detection of vulnerable atherosclerotic plaques
por: Horvath, Martin, et al.
Publicado: (2016)

Effect of transglutaminase 2 (TG2) deficiency on atherosclerotic plaque stability in the apolipoprotein E deficient mouse
por: Williams, Helen, et al.
Publicado: (2010)

Impact of Alirocumab on Release Markers of Atherosclerotic Plaque Vulnerability in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque
por: Kosowski, Michał, et al.
Publicado: (2022)

Association of Lipoprotein(a) With Atherosclerotic Plaque Progression
por: Kaiser, Yannick, et al.
Publicado: (2022)

Osteopontin and osteoprotegerin in atherosclerotic plaque – are they significant markers of plaque vulnerability?
por: Strobescu-Ciobanu, Cristina, et al.
Publicado: (2020)

MicroRNA-33 Deficiency Reduces the Progression of Atherosclerotic Plaque in ApoE(−/−) Mice
por: Horie, Takahiro, et al.
Publicado: (2012)

Salidroside Decreases Atherosclerotic Plaque Formation in Low-Density Lipoprotein Receptor-Deficient Mice
por: Zhang, Bu-Chun, et al.
Publicado: (2012)

Myeloid cell-specific Irf5 deficiency stabilizes atherosclerotic plaques in Apoe(–/–) mice
por: Leipner, Julia, et al.
Publicado: (2021)

The Elusive Origin of Atherosclerotic Plaque Calcification
por: Canet-Soulas, Emmanuelle, et al.
Publicado: (2021)

Clinical Molecular Imaging for Atherosclerotic Plaque
por: Kondakov, Anton, et al.
Publicado: (2021)

Cellular crosstalk in atherosclerotic plaque microenvironment
por: Mahdinia, Elmira, et al.
Publicado: (2023)

Residual risks and evolving atherosclerotic plaques
por: Noothi, Sunil K., et al.
Publicado: (2023)

Interferon regulatory factor-5-dependent CD11c(+) macrophages contribute to the formation of rupture–prone atherosclerotic plaques
por: Edsfeldt, Andreas, et al.
Publicado: (2022)

Cholesterol accumulation in macrophages drives NETosis in atherosclerotic plaques via IL-1β secretion
por: Yalcinkaya, Mustafa, et al.
Publicado: (2022)

Evaluating guselkumab: an anti-IL-23 antibody for the treatment of plaque psoriasis
por: Yang, Eric J, et al.
Publicado: (2019)

Indoleamine 2,3‐dioxygenase 1 in coronary atherosclerotic plaque enhances tissue factor expression in activated macrophages
por: Watanabe, Yuki, et al.
Publicado: (2018)

Correlation Between Calcification Characteristics of Carotid Atherosclerotic Plaque and Plaque Vulnerability
por: Xu, Xiangli, et al.
Publicado: (2021)

Xyloketal B Attenuates Atherosclerotic Plaque Formation and Endothelial Dysfunction in Apolipoprotein E Deficient Mice
por: Zhao, Li-Yan, et al.
Publicado: (2015)

Radiofrequency Ablation of the Atherosclerotic Plaque: a Proof of Concept Study in an Atherosclerotic Model
por: Ellenbroek, Guilielmus H.J.M., et al.
Publicado: (2017)

Error Propagation in the Simulation of Atherosclerotic Plaque Growth and the Prediction of Atherosclerotic Disease Progression
por: Sakellarios, Antonis I., et al.
Publicado: (2021)

Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation
por: Tang, Jun, et al.
Publicado: (2015)

Expression of osteopontin in calcified coronary atherosclerotic plaques.
por: Kwon, H. M., et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_flpblihmc7f5ppbs2eg9gqoide